Telehealth company Ro said on Wednesday it will provide access to single-dose vials of Eli Lilly's weight-loss drug Zepbound ...

Eli Lilly and Co. will begin studies to see if its blockbuster weight-loss medicines are also effective at controlling addictive behaviors like alcohol abuse, smoking and drug addiction, Chief ...

Eli Lilly (LLY), the pharma giant that produces the popular weight-loss drug Zepbound, said it plans to test the blockbuster ...

Eli Lilly will launch studies to investigate whether its weight loss medications can help control addictive behaviors such as smoking and alcohol and drug abuse, CEO Dave Ricks revealed in a Dec. 10 ...

Ozempic and other GLP-1 drugs have surged in popularity, dominating U.S. medication spending in 2023 for their effectiveness in managing diabetes and promoting weight loss. As demand grows, promising ...

The NHS will deny 90 per cent of eligible obese patients the “King Kong” of weight loss jabs, citing budget pressures ...

W ith more people taking the weight-loss drugs Wegovy and Zepbound, one question inevitably arises: which one is more ...

Millions of Americans who have obesity could gain insurance coverage for drugs like Wegovy if the Trump administration allows ...

Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or ...

Lp(a) levels are determined by a person's genes, so lifestyle changes such as diet or exercise have no ... to design a phase three trial on the pill. Eli Lilly estimates that "it's probably ...

Analysts say Eli Lilly may have a future blockbuster drug on its hands: An experimental pill designed to lower ... so lifestyle changes such as diet or exercise have no effect, Ruth Gimeno ...